Carboplatin and Paclitaxel with vs without Bevacizumab in Older Patients with Advanced Non-Small-Cell Lung Cancer

CONTEXT: A randomized trial demonstrates that adding bevacizumab to carboplatin and paxlitaxel improves survival in advanced non-small-cell lung cancer (NSCLC). OBJECTIVE: To examine whether adding bevacizumab to carboplatin and paclitaxel chemotherapy is associated with improved survival in the NSC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhu, Junya, Sharma, Dhruv B., Gray, Stacy W., Chen, Aileen B., Weeks, Jane C., Schrag, Deborah
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3418968/
https://ncbi.nlm.nih.gov/pubmed/22511687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2012.454
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados